Evogene (TSE:EVGN – Free Report) had its price objective reduced by Pi Financial from C$5.00 to C$4.00 in a research note released on Wednesday, BayStreet.CA reports. Evogene Price Performance Evogene Company Profile (Get Free Report) Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including […]
Evogene (TSE:EVGN – Free Report) had its price objective cut by Echelon Wealth Partners from C$6.25 to C$6.00 in a report released on Friday morning, BayStreet.CA reports. They currently have a buy rating on the stock. Separately, Desjardins cut their target price on shares of Evogene from C$4.50 to C$4.25 and set a buy rating […]
Evogene (TSE:EVGN – Get Free Report) had its target price cut by stock analysts at Desjardins from C$4.50 to C$4.25 in a report issued on Monday, BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Evogene Stock Performance About Evogene (Get Free Report) Evogene is a leading computational biology company focused on […]
Evogene (TSE:EVGN – Get Rating) had its target price trimmed by Pi Financial from C$8.00 to C$7.50 in a report issued on Friday morning, BayStreet.CA reports. Evogene Stock Performance Evogene Company Profile (Get Rating) Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human […]